BOULDER, Colo., June 18, 2026 /PRNewswire/ — KROMATID, a leader in structural genomic integrity analysis for the cell and gene therapy industry, today announced the appointment of Matthew Hemstreet as Chief Executive Officer, succeeding Interim CEO Terry Opgenorth. KROMATID announces…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
